Huateng Pharmaceutical, a global supplier of API intermediates, offers Carfilzomib intermediate Morpholin-4-ylacetic acid (CAS No.: 3235-69-6) for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation.

Application: An intermediate of Carfilzomib (C183460) which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.